scispace - formally typeset
Open AccessJournal ArticleDOI

Detection of the A2058G and A2059G 23S rRNA Gene Point Mutations Associated with Azithromycin Resistance in Treponema pallidum by Use of a TaqMan Real-Time Multiplex PCR Assay

TLDR
The TaqMan-based real-time triplex PCR assay offers an alternative to conventional nested PCR and restriction fragment length polymorphism analyses for the rapid detection of both point mutations associated with macrolide resistance in T. pallidum.
Abstract
Macrolide treatment failure in syphilis patients is associated with a single point mutation (either A2058G or A2059G) in both copies of the 23S rRNA gene in Treponema pallidum strains. The conventional method for the detection of both point mutations uses nested PCR combined with restriction enzyme digestions, which is laborious and time-consuming. We initially developed a TaqMan-based real-time duplex PCR assay for detection of the A2058G mutation, and upon discovery of the A2059G mutation, we modified the assay into a triplex format to simultaneously detect both mutations. The point mutations detected by the real-time triplex PCR were confirmed by pyrosequencing. A total of 129 specimens PCR positive for T. pallidum that were obtained from an azithromycin resistance surveillance study conducted in the United States were analyzed. Sixty-six (51.2%) of the 129 samples with the A2058G mutation were identified by both real-time PCR assays. Of the remaining 63 samples that were identified as having a macrolide-susceptible genotype by the duplex PCR assay, 17 (27%) were found to contain the A2059G mutation by the triplex PCR. The proportions of macrolide-susceptible versus -resistant genotypes harboring either the A2058G or the A2059G mutation among the T. pallidum strains were 35.6, 51.2, and 13.2%, respectively. None of the T. pallidum strains examined had both point mutations. The TaqMan-based real-time triplex PCR assay offers an alternative to conventional nested PCR and restriction fragment length polymorphism analyses for the rapid detection of both point mutations associated with macrolide resistance in T. pallidum.

read more

Citations
More filters
Journal ArticleDOI

The Endemic Treponematoses

TL;DR: All human treponematoses share remarkable similarities in pathogenesis and clinical manifestations, consistent with the high genetic and antigenic relatedness of their etiological agents.
Journal ArticleDOI

Syphilis: Re-emergence of an old foe.

TL;DR: Genomic and proteomic studies have provided some new information concerning how this spirochete may evade host defense mechanisms to persist for long periods in the host.
Journal ArticleDOI

Syphilis: antibiotic treatment and resistance.

TL;DR: Information is presented here on the diagnosis and recommended antibiotic treatment of syphilis and the challenge of macrolide-resistant T. pallidum.
Journal ArticleDOI

A Cross-Sectional Study of ‘Yaws’ in Districts of Ghana Which Have Previously Undertaken Azithromycin Mass Drug Administration for Trachoma Control

TL;DR: A cross-sectional survey in thirty communities in two districts of Ghana, previously treated for trachoma, found no evidence of ongoing transmission of yaws and integration of diagnostic testing into both pre and post-MDA surveillance systems is required to better inform yaws control programmes.
References
More filters

Sexually transmitted diseases treatment guidelines, 2010.

TL;DR: These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18-30, 2009.
Journal ArticleDOI

Macrolide Resistance Conferred by Base Substitutions in 23S rRNA

TL;DR: The observation that erythromycin-resistant strains were cross-resistant not only to all other macrolides but also to the chemically unrelated lincosamide and streptogramin B drugs was disquieting.
Journal ArticleDOI

Macrolide resistance in Treponema pallidum in the United States and Ireland

TL;DR: An HIV-infected patient in San Francisco with primary syphilis was treated with azithromycin, but the lesion did not resolve, and a mutation in the 23S rRNA genes of T. pallidum was identified.
Journal ArticleDOI

Single-Dose Azithromycin versus Penicillin G Benzathine for the Treatment of Early Syphilis

TL;DR: Single-dose oral azithromycin is effective in treating syphilis and may be particularly useful in developing countries in which the use of penicillin G benzathine injections is problematic, however, recent reports of azitromycin-resistant Treponema pallidum in the United States indicate the importance of continued monitoring for resistance.
Journal ArticleDOI

A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis.

TL;DR: Oral therapy with 2.0 g of azithromycin as a single dose or as two doses 1 week apart is a promising alternative to therapy with benzathine penicillin G for syphilis and should be studied further.
Related Papers (5)